from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2615c/PE_PGRS45

LFCtreatmentdescriptionclass of inhibitor

-0.071

Amikacinug/mL Amikacintranslation

0.168

Cap5-10ug/mL Capreomycintranslation

0.486

Rox10-50 ug/mL Roxithromycintranslation

-0.079

SM2-5 ug/mL Streptomycintranslation

0.126

Tet5-10 ug/mL Tetracyclinetranslation

0.225

Rif0.2-5ug/mL Rifampicintranscription

0.350

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.681

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.513

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.270

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.311

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.637

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.293

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.791

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.206

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.705

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.800

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.128

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.519

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.052

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.051

KCN5-20 ug/mL Potassium cyaniderespiration

-0.693

NaN30.2-2 mM Sodium aziderespiration

-0.043

Nigericin50 uM Nigericinrespiration

1.364

TRC10-150 ug/mL Triclosanrespiration

-0.312

TRZ10-25 ug/mL Thioridazinerespiration

1.135

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.427

menadione6-10 ug/mL Menadionerespiration

-0.038

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.299

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.006

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.565

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.915

NRP_1Non-replicating persistence stage 1dosRassociated

-0.465

Amp0.2mg/mL AmpicillincellWall

-1.249

Cephalexin20-100 ug/mL CephalexincellWall

0.965

Cerulenin0.32-5 ug/mL CerulenincellWall

0.228

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.081

EMB10-20 ug/mL EthambutolcellWall

-0.164

Eta12-40 ug/mL EthionamidecellWall

-0.021

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.726

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.209

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.147

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.642

BZA0.12 mg/mL BenzamidearomaticAmides

0.429

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.241

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.211

H2O24 mM hydrogen peroxideDNAdamaging

0.015

Levo10 ug/mL LevofloxacinDNAdamaging

-0.274

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.043

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.049

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.088

UVUV-irradiationDNAdamaging

1.777

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.048

Antimycin12.5-50 ug/mL Antimycin A?

-0.549

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.717

PA_110-50 ug/mL Antitubercular compound PA-1?

0.228

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.875

PA8240.2-2 ug/mL PA-824?

1.545

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.112

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.284

Verapamil50 uM Verapamil?

-0.596

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.217

methoxatin10-20 ug/mL Methoxatin?